# Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)

> **NCT04088513** · PHASE4 · UNKNOWN · sponsor: **First Affiliated Hospital, Sun Yat-Sen University** · enrollment: 440 (estimated)

## Conditions studied

- G6PD Deficiency
- Stroke

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Clopidogrel

## Key facts

- **NCT ID:** NCT04088513
- **Lead sponsor:** First Affiliated Hospital, Sun Yat-Sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-01-22
- **Primary completion:** 2024-12-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 440 (ESTIMATED)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04088513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04088513, "Safety and Efficacy of Aspirin in Stroke Patients With Glucose-6-phosphate Dehydrogenase Deficiency (SAST)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04088513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*